Gut emotions - Mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 10, 2014, Pages 1770-1786

  Slyepchenko, Anastasiya ^a   Carvalho, Andre F ^b   Cha, Danielle S ^a   Kasper, Siegfried ^c   McIntyre, Roger S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anxiety; Depression; Gut microbiota; Probiotics; Review; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY DISORDER; ARTICLE; BACTERIAL INFECTION; BEHAVIORAL SCIENCE; BRAIN FUNCTION; DEPRESSION; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; EXPERIMENTAL DEPRESSION TEST; GENE EXPRESSION; HEART INFARCTION; HORMONE RELEASE; HUMAN; MICROBIAL COLONIZATION; MICROBIOME; NERVE CELL NETWORK; NEUROTRANSMISSION; ORGANISMAL INTERACTION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRESS; SYSTEMATIC REVIEW; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME; ANIMAL; ANXIETY DISORDERS; MICROFLORA;

ANIMALS; ANXIETY DISORDERS; DEPRESSION; HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84924164868     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527313666141130205242     Document Type: Article

References (75)

1. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336(6086): 1268-73.
2. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291(5505): 881-4.
3. Frank DN, Amand ALS, Feldman RA, et al. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104(34): 13780-5.
4. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489(7415): 220-30.
5. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLOS Biol 2007; 5(7): e177-e.
6. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesityassociated gut microbiome with increased capacity for energy harvest. Nature 2006; 444(7122): 1027-31.
7. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroentero 2009; 6(5): 306-14.
8. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12(8): 453-66.
9. Öngür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000; 10(3): 206-19.
10. Price JL, Carmichael ST, Drevets WC. Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior? Prog Brain Res 1995; 107: 523-36.
11. Furness JB. The Enteric Nervous System. John Wiley & Sons; 2008.
12. Furness JB, Jones C, Nurgali K, Clerc N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Progr Neurobiol 2004; 72(2): 143-64.
13. Schwartz GJ. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 2000; 16(10): 866-73.
14. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132(1): 397-414.
15. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8(6): 411-20.
16. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol 2011; 35(3): 702-21.
17. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun 2010; 24(1): 9-16.
18. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II-contemporary contextual research. Gut Pathog 2013; 5(1): 3.
19. Park AJ, Collins J, Blennerhassett PA, et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroent Motil 2013; 25(9): 733.
20. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141(2): 599-609.
21. Clarke G, Grenham S, Scully P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatr 2013; 18(6): 666-73.
22. Gareau MG, Wine E, Rodrigues DM, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60(3): 307-17.
23. Heijtz RD, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108(7): 3047-52.
24. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxietylike behavior and central neurochemical change in germ-free mice. Neurogastroent Motil 2011; 23(3): 255-64, e119.
25. Nishino R, Mikami K, Takahashi H, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroent Motil 2013; 25(6): 521-8.
26. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558(1): 263-75.
27. Bendtsen KMB, Krych L, Sorensen DB, et al. Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PloS One 2012; 7(10): e46231-e.
28. Crumeyrolle-Arias M, Jaglin M, Bruneau A, et al. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 2014; 42: 207-17.
29. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behavior-epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014; 13(1): 69-86.
30. Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RP. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 2008; 22(3): 354-66.
31. Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006; 89(3): 350-7.
32. Matthews DM, Jenks SM. Ingestion of Mycobacterium vaccae decreases anxiety-related behavior and improves learning in mice. Behav Process 2013; 96: 27-35.
33. Savignac HM, Corona G, Mills H, et al. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int 2013; 63(8): 756-64.
34. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011; 105(5): 755-64.
35. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiat Res 2008; 43(2): 164-74.
36. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011; 108(38): 16050-5.
37. Perez-Burgos A, Wang B, Mao YK, et al. Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am J Physiol Gastr L 2013; 304(2): G211-20.
38. Bercik P, Verdu EF, Foster JA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139(6): 2102-12. e1.
39. Bercik P, Park AJ, Sinclair D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroent Motil 2011; 23(12): 1132-9.
40. van der Kleij H, O'Mahony C, Shanahan F, O'Mahony L, Bienenstock J. Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Reg 2008; 295(4): R1131-7.
41. Desbonnet L, Garrett L, Clarke G, et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170(4): 1179-88.
42. Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007; 56(11): 1522-8.
43. Ait-Belgnaoui A, Colom A, Braniste V, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroent Motil 2014; 26(4): 510-20.
44. Meijer A, Conradi HJ, Bos EH, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data metaanalysis. Brit J Psychiat 2013; 203(2): 90-102.
45. Arseneault-Breard J, Rondeau I, Gilbert K, et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr 2012; 107(12): 1793-9.
46. Gilbert K, Arseneault-Breard J, Monaco FF, et al. Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion. Br J Nutr 2013; 109(1): 50-6.
47. Ohland CL, Kish L, Bell H, et al. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrino 2013; 38(9): 1738-47.
48. Kantak PA, Bobrow DN, Nyby JG. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG). Behav Pharmacol 2014; 25(1): 71-9.
49. Luo J, Wang T, Liang S, et al. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Ser C 2014; 57(3): 327-35.
50. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroent Motil 2010; 22(9): 1029-35.
51. Yang H, Zhao X, Tang S, et al. Probiotics reduce psychological stress in patients before laryngeal cancer surgery. Asia Pac J Clin Oncol 2015; Epub ahead of print.
52. Rao AV, Bested AC, Beaulne TM, et al. A randomized, doubleblind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009; 1(1): 6.
53. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007; 61(3): 355-61.
54. Diop L, Guillou S, Durand H. Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a doubleblind, placebo-controlled, randomized trial. Nutr Res 2008; 28(1): 1-5.
55. Tillisch K, Labus J, Kilpatrick L, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013; 144(7): 1394-401.
56. Nugent NR, Tyrka AR, Carpenter LL, Price LH. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology 2011; 214(1): 175-96.
57. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53(4): 865-71.
58. Gold PW. Evidence that stress per se has a role in the precipitation and natural history of depressive illness. Mol Psychiatr 2013; 18(9): 954-6.
59. Numakawa T, Adachi N, Richards M, Chiba S, Kunugi H. Brainderived neurotrophic factor and glucocorticoids: reciprocal influence on the central nervous system. Neuroscience 2013; 239: 157-72.
60. Brunoni AR, Lopes M, Fregni F. A systematic review and metaanalysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11(8): 1169-80.
61. Molendijk ML, Bus BA, Spinhoven P, et al. Serum levels of brainderived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011; 16(11): 1088-95.
62. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiat 2010; 67(5): 446-57.
63. Naseribafrouei A, Hestad K, Avershina E, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 2014; 26(8): 1155-62.
64. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol 2010; 12: 5-9.
65. Duman RS. Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism. Neurobiol Aging 2005; 26(1): 88-93.
66. Insel TR. The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry. Am J Psychiat 2014; 171(4): 395-7.
67. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 1985; 14(3): 149-67.
68. Walsh RN, Cummins RA. The open-field test: A critical review. Psychol Bull 1976; 83(3): 482-504.
69. Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 1998; 350(1): 21-9.
70. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997; 8(6-7): 523-32.
71. Rosenfeld CS, Ferguson SA. Barnes Maze Testing Strategies with Small and Large Rodent Models. J Vis Exp 2014(84): e51194.
72. Bourin M, Hascoet M. The mouse light/dark box test. Eur J Pharmacol 2003; 463(1): 55-65.
73. Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav R 2005; 29(4): 571-625.
74. Adriaan Bouwknecht J, Olivier B, Paylor RE. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci Biobehav R 2007; 31(1): 41-59.
75. Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155(7): 1451-63.